Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disorders

Cancer Immunology, Immunotherapy : CII
Katharina C KählerGerman Dermatologic Cooperative Oncology Group (DeCOG)

Abstract

Ipilimumab and programmed death (PD) 1-antibodies are effective treatment options in metastatic melanoma. The safety and efficacy of ipilimumab in patients with pre-existing autoimmune disorders (AD) has only been evaluated in a selected number of patients. We performed a retrospective analysis in 14 German skin cancer centers for patients with metastatic melanoma and pre-existing AD treated with ipilimumab. 41 patients with 44 pre-existing AD were treated with ipilimumab (thyroiditis n = 15, rheumatoid n = 11, dermatologic n = 10, Crohn's disease/ulcerative colitis n = 3, neurological n = 2, sarcoidosis n = 2, pancreatitis n = 1). 3 out of 41 patients had two AD, 11 patients required immunosuppressants at the time of induction of ipilimumab. 12 patients (29.2%) experienced a flare of their pre-existing AD, mainly patients with rheumatoid or dermatologic diseases. Additional immune-related adverse events (irAEs) occurred in 12 patients (29.2%). In 23 patients (56%) neither a change of their AD nor additional irAEs were observed. Objective responses were seen in five patients (one complete remission, four partial remissions, 12.1%). This is the largest series of patients with pre-existing AD and treatment with ipilimumab reporte...Continue Reading

References

Aug 10, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter AttiaSteven A Rosenberg
Nov 6, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stephanie G DowneySteven A Rosenberg
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Nov 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles M BalchVernon K Sondak
Sep 18, 2014·Cancer Immunology, Immunotherapy : CII·Magnus PedersenInge Marie Svane
Oct 29, 2014·Journal for Immunotherapy of Cancer·Chrisann KyiMichael A Postow
Jan 22, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hansje-Eva TeulingsRosalie M Luiten
Jul 30, 2015·JAMA Dermatology·Martina SanlorenzoSusana Ortiz-Urda
Mar 10, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C BenderJ C Hassel
Apr 17, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Lisa ZimmerLucie M Heinzerling
Feb 20, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ralf GutzmerUNKNOWN German Dermatooncology Group (DeCOG)
Aug 26, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dirk SchadendorfMichael A Postow

❮ Previous
Next ❯

Citations

Aug 23, 2018·Gut·Emilie SoularueFranck Carbonnel
Aug 6, 2019·Arthritis & Rheumatology·Alice TisonUNKNOWN Groupe de Cancérologie Cutanée, Groupe Français de Pneumo-Cancérologie, and Club Rhumatismes et Inflammations
Jan 11, 2020·The American Journal of Gastroenterology·Emanuelle Bellaguarda, Stephen Hanauer
Oct 15, 2019·Arthritis & Rheumatology·Alice TisonDivi Cornec
Apr 19, 2020·Journal for Immunotherapy of Cancer·Patrick BolandSabina Sandigursky
Mar 15, 2019·Current Opinion in Rheumatology·Xerxes PundoleMaria E Suarez-Almazor
May 28, 2020·International Journal of Colorectal Disease·Maho IwamotoSatoru Takahashi
Sep 8, 2020·Asia-Pacific Journal of Clinical Oncology·Siyuan FanHongzhi Guan
Dec 10, 2019·Rheumatology·Jan Leipe, Xavier Mariette
May 10, 2020·Nature Reviews. Disease Primers·Manuel Ramos-CasalsMaria E Suárez-Almazor
Aug 5, 2020·Gut·Matthias PinterMarkus Peck-Radosavljevic
Oct 28, 2019·Frontline Gastroenterology·Vincent CheungJeremy F Cobbold
Apr 9, 2020·Thyroid : Official Journal of the American Thyroid Association·Christopher A MuirVenessa H M Tsang
Mar 21, 2020·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J HaanenM Obeid
Oct 9, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Yi-He LiuPeng Zhang
Oct 23, 2020·Vaccines·Mohamed A Abd El AzizRodolfo Sacco
Dec 11, 2020·The Cancer Journal·Mitchell S von ItzsteinDavid E Gerber
Dec 12, 2020·Cancers·Danielle B TometichLaura Oswald
Oct 16, 2020·Clinical Journal of Gastroenterology·Atsuto KayashimaTakanori Kanai
Mar 7, 2020·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Huaxia YangFengchun Zhang
Mar 2, 2021·Immunotherapy·Sang T KimMaria E Suarez-Almazor
Nov 19, 2020·JHEP Reports : Innovation in Hepatology·Eleonora De MartinDidier Samuel
Feb 3, 2020·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Michael CollinsFranck Carbonnel
Oct 13, 2021·Journal for Immunotherapy of Cancer·Briana Rose HalleVeronica M Rotemberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Ralf GutzmerGerman Dermatooncology Group (DeCOG)
Annals of Oncology : Official Journal of the European Society for Medical Oncology
A M MenziesG V Long
The Oncologist
Michael A PostowRichard D Carvajal
© 2022 Meta ULC. All rights reserved